| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185012C DNA vaccine pVFS of SARS virus |
| 01/19/2005 | CN1185011C DNA vaccine pVPS of SARS virus |
| 01/19/2005 | CN1184990C Medicine bag for treating asthma |
| 01/19/2005 | CN1184968C Antibiotic compositions for treatment of the eye, ear and nose |
| 01/19/2005 | CN1184963C Bromhexine hydrochloride injection and its preparation method |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/18/2005 | US6845245 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844354 Agent for prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosis |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/18/2005 | US6843392 Valve with a valve stem wiper |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/16/2005 | CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold |
| 01/13/2005 | WO2005003115A1 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/13/2005 | WO2005003114A1 5-fluoro-thiopen-compounds,the process for their preparation,the pharmaceutical compositions containing them and their use as metallopotenases inhibitors |
| 01/13/2005 | WO2005003090A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/13/2005 | WO2005002667A1 Portable electrotherapy device for knee joint maladies |
| 01/13/2005 | WO2005002610A1 Traditional chinese medicine for treating and preventing sars virus |
| 01/13/2005 | WO2005002598A1 Mouth and/or throat wash |
| 01/13/2005 | WO2005002593A1 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 01/13/2005 | WO2005002572A2 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | US20050010264 Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint |
| 01/13/2005 | US20050010052 P2X7 receptor (a ligand-gated ion channel) antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases; osteoarthritis |
| 01/13/2005 | US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050009923 Bronchodilating beta-agonist compositions and methods |
| 01/13/2005 | US20050009914 Increasing the production of the blood-forming hormone erythropoietin, especially for the treatment of aging- or disease-related conditions associated with decreased oxygen supply to the tissue, especially in elderly subjects, in the treatment of malignant diseases and in cardiorespiratory disorders |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009857 Powder formulations containing tiotropium suitable for inhalation |
| 01/13/2005 | US20050009845 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009795 Mixtures or organic compounds for the treatment of airway diseases |
| 01/13/2005 | US20050009777 Non-natural carbon-linked nucleotides and dinucleotides |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009073 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 01/13/2005 | US20050009056 Anti-infective therapy |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | CA2532066A1 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 01/13/2005 | CA2530922A1 Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 01/13/2005 | CA2525801A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists |
| 01/12/2005 | EP1496059A1 Fused bicyclic pyrimidine derivatives |
| 01/12/2005 | EP1495757A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative |
| 01/12/2005 | EP1495756A1 Severe sepsis preventive therapeutic agent |
| 01/12/2005 | EP1495053A2 Angiopoietin-2 specific binding agents |
| 01/12/2005 | EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same |
| 01/12/2005 | EP1495022A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 01/12/2005 | EP1495020A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases |
| 01/12/2005 | EP1495017A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 01/12/2005 | EP1495016A2 Heterocyclic compounds and their use as modulators of p38 map kinase |
| 01/12/2005 | EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494722A1 Treatment methods for eotaxin mediated inflammatory conditions |
| 01/12/2005 | EP1494711A1 Methods for treating chronic obstructive pulmonary disease (copd) |
| 01/12/2005 | EP1494698A2 Compositions and methods for treating and preventing necrosis |
| 01/12/2005 | EP1494696A2 Treatment of lung disorder |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494653A1 Sustained release pharmaceutical prepartations and methods for producing the same |
| 01/12/2005 | EP1494648A1 Powder formulations suitable for inhalation |
| 01/12/2005 | EP1494645A2 Method of treating mucus hypersecretion |
| 01/12/2005 | EP1494644A1 Dry powder compositions |
| 01/12/2005 | EP1307216A4 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/12/2005 | EP1231894B1 Pharmaceutical formulations of salmeterol |
| 01/12/2005 | EP1194044B1 Pharmaceutical or dietetic mushroom-based compositions and their use |
| 01/12/2005 | EP1183254B1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 01/12/2005 | EP1117387B1 Coated medicament forms with controlled active substance release |
| 01/12/2005 | EP1105370B9 Novel aryl sulphonamides and analogues |
| 01/12/2005 | EP1063987A4 Dietary control of arachidonic acid metabolism |
| 01/12/2005 | EP0996460B1 Treatment of kidney fibrosis with antibodies against integrin alpha-v-beta 6 |
| 01/12/2005 | EP0958823B1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1564821A 5-methoxy-8-aryl-[1, 2, 4]triazolo[1, 5-a]pyridine derivatives as adenosine receptor antagonists |
| 01/12/2005 | CN1564696A Compositions for and methods of treating and preventing sirs/sepsis |
| 01/12/2005 | CN1564692A Fever bringing down formulating for preventing virus and its prepn. method |
| 01/12/2005 | CN1564691A Interval drug release system of convulsion relieving agent |
| 01/12/2005 | CN1564688A Methods of treating pulmonary disease |
| 01/12/2005 | CN1564686A 8-amino- [1, 2, 4]triazolo [1, 5-a]pyridine-6-carboxylic acid amide |